# Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients

> **NCT00823966** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 3 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** Rescriptor

## Key facts

- **NCT ID:** NCT00823966
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2010-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00823966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00823966, "Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00823966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*